ETF Series Solutions
Loncar China BioPharma ETF
$5.08M
Avg Monthly Net Assets
$4.16M
Total Assets
$4K
Total Liabilities
$4.16M
Net Assets
Loncar China BioPharma ETF is an Exchange-Traded Fund in ETF Series Solutions
,
based in Wisconsin,
United States of America.
The fund has one share class
and monthly net assets of $5.08M.
On October 30th, 2023 it reported 67 holdings, the largest
being AIM Vaccine Co Ltd (4.5%), Legend Biotech Corp (3.1%) and WuXi AppTec Co Ltd (2.7%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Loncar China BioPharma ETF | C000203299 | XNAS | CHNA |
Holdings
From latest NPORT-P, filed October 30th, 2023 for period ending August 31st, 2023.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 3D Medicines Inc | Long | Equity-common | CN | $34K | 10K | 0.81 |
| 3SBio Inc | Long | Equity-common | CN | $71K | 85K | 1.71 |
| AIM Vaccine Co Ltd | Long | Equity-common | CN | $185K | 29K | 4.45 |
| Akeso Inc | Long | Equity-common | CN | $66K | 15K | 1.58 |
| Alphamab Oncology | Long | Equity-common | CN | $52K | 47K | 1.24 |
| Antengene Corp Ltd | Long | Equity-common | CN | $15K | 99K | 0.37 |
| Ascentage Pharma Group International | Long | Equity-common | CN | $75K | 24K | 1.81 |
| Ascletis Pharma Inc | Long | Equity-common | CN | $34K | 121K | 0.82 |
| Asymchem Laboratories Tianjin Co Ltd | Long | Equity-common | CN | $75K | 6K | 1.80 |
| BeiGene Ltd | Long | Equity-common | US | $105K | 507 | 2.53 |
| Biocytogen Pharmaceuticals Beijing Co Ltd | Long | Equity-common | CN | $65K | 28K | 1.57 |
| Brii Biosciences Ltd | Long | Equity-common | CN | $23K | 62K | 0.54 |
| Burning Rock Biotech Ltd | Long | Equity-common | CN | $28K | 21K | 0.68 |
| CanSino Biologics Inc | Long | Equity-common | CN | $31K | 10K | 0.73 |
| CARsgen Therapeutics Holdings Ltd | Long | Equity-common | CN | $46K | 39K | 1.11 |
| China Medical System Holdings Ltd (CMS) | Long | Equity-common | HK | $75K | 52K | 1.81 |
| China Resources Pharmaceutical Group Ltd (CHINARES PHARMA) | Long | Equity-common | CN | $78K | 116K | 1.86 |
| CK Life Sciences Int'l Holdings Inc (CKLIFE SCIENCES) | Long | Equity-common | HK | $82K | 876K | 1.96 |
| Clover Biopharmaceuticals Ltd | Long | Equity-common | CN | $30K | 198K | 0.72 |
| CSPC Pharmaceutical Group Ltd | Long | Equity-common | CN | $83K | 111K | 2.01 |
| CStone Pharmaceuticals | Long | Equity-common | CN | $30K | 107K | 0.73 |
| Everest Medicines Ltd | Long | Equity-common | CN | $75K | 33K | 1.80 |
| First American Government Obligations Fund | Long | Short-term investment vehicle | US | $35K | 35K | 0.83 |
| Genscript Biotech Corp | Long | Equity-common | CN | $66K | 28K | 1.58 |
| Grand Pharmaceutical Group Ltd | Long | Equity-common | HK | $76K | 146K | 1.82 |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (BAIYUNSHAN PH) | Long | Equity-common | CN | $87K | 31K | 2.10 |
| Hangzhou Tigermed Consulting Co Ltd (TIGERMED) | Long | Equity-common | CN | $53K | 10K | 1.27 |
| Hansoh Pharmaceutical Group Co Ltd | Long | Equity-common | CN | $83K | 64K | 2.00 |
| HBM Holdings Ltd | Long | Equity-common | CN | $34K | 156K | 0.81 |
| Hua Medicine | Long | Equity-common | CN | $23K | 105K | 0.54 |
| HUTCHMED China Ltd | Long | Equity-common | HK | $74K | 5K | 1.79 |
| I-Mab | Long | Equity-common | CN | $25K | 13K | 0.59 |
| Immunotech Biopharm Ltd | Long | Equity-common | CN | $34K | 55K | 0.81 |
| InnoCare Pharma Ltd | Long | Equity-common | CN | $43K | 51K | 1.04 |
| Innovent Biologics Inc | Long | Equity-common | CN | $74K | 17K | 1.78 |
| Jacobio Pharmaceuticals Group Co Ltd | Long | Equity-common | CN | $36K | 73K | 0.86 |
| Jiangsu Recbio Technology Co Ltd | Long | Equity-common | CN | $42K | 29K | 1.01 |
| Joinn Laboratories China Co Ltd | Long | Equity-common | CN | $51K | 26K | 1.23 |
| JW Cayman Therapeutics Co Ltd | Long | Equity-common | CN | $28K | 96K | 0.67 |
| Keymed Biosciences Inc | Long | Equity-common | CN | $65K | 10K | 1.55 |
| Kintor Pharmaceutical Ltd | Long | Equity-common | CN | $21K | 48K | 0.51 |
| Legend Biotech Corp | Long | Equity-common | US | $128K | 2K | 3.07 |
| Lepu Biopharma Co Ltd | Long | Equity-common | CN | $65K | 98K | 1.57 |
| LianBio | Long | Equity-common | KY | $51K | 28K | 1.22 |
| Livzon Pharmaceutical Group Inc (LIVZON GROUP) | Long | Equity-common | CN | $82K | 26K | 1.97 |
| Luye Pharma Group Ltd | Long | Equity-common | CN | $64K | 173K | 1.53 |
| New Horizon Health Ltd | Long | Equity-common | CN | $48K | 22K | 1.14 |
| Ocumension Therapeutics | Long | Equity-common | CN | $68K | 65K | 1.65 |
| Pharmaron Beijing Co Ltd | Long | Equity-common | CN | $64K | 27K | 1.54 |
| Remegen Co Ltd | Long | Equity-common | CN | $51K | 11K | 1.23 |
| SciClone Pharmaceuticals Holdings Ltd | Long | Equity-common | CN | $62K | 52K | 1.49 |
| Shanghai Fosun Pharmaceutical Group Co Ltd (FOSUN PHARMA) | Long | Equity-common | CN | $95K | 41K | 2.29 |
| Shanghai Haohai Biological Technology Co Ltd (HAOHAI BIOTEC) | Long | Equity-common | CN | $103K | 18K | 2.47 |
| Shanghai Junshi Biosciences Co Ltd | Long | Equity-common | CN | $54K | 20K | 1.30 |
| Shanghai Pharmaceuticals Holding Co Ltd (SH PHARMA) | Long | Equity-common | CN | $85K | 52K | 2.05 |
| Sihuan Pharmaceutical Holdings Group Ltd | Long | Equity-common | CN | $57K | 696K | 1.37 |
| Simcere Pharmaceutical Group Ltd | Long | Equity-common | CN | $50K | 64K | 1.20 |
| Sino Biopharmaceutical Ltd | Long | Equity-common | HK | $83K | 219K | 2.00 |
| Sinopharm Group Co Ltd | Long | Equity-common | CN | $106K | 37K | 2.56 |
| Sirnaomics Ltd | Long | Equity-common | US | $59K | 9K | 1.41 |
| SSY Group Ltd | Long | Equity-common | HK | $80K | 151K | 1.93 |
| Viva Biotech Holdings | Long | Equity-common | CN | $51K | 276K | 1.24 |
| WuXi AppTec Co Ltd | Long | Equity-common | CN | $112K | 10K | 2.70 |
| Wuxi Biologics Cayman Inc | Long | Equity-common | CN | $84K | 15K | 2.03 |
| YiChang HEC ChangJiang Pharmaceutical Co Ltd (HEC CJ PHARM) | Long | Equity-common | CN | $52K | 64K | 1.24 |
| Zai Lab Ltd | Long | Equity-common | CN | $60K | 2K | 1.44 |
| Zhaoke Ophthalmology Ltd | Long | Equity-common | CN | $42K | 90K | 1.02 |
Address
ETF Series Solutions
c/o U.S. Bancorp Fund Services LLC
615 East Michigan Street
Milwaukee
Wisconsin
53202
United States of America
Websites
Directors
Leonard M. Rush
David A. Massart
Janet D. Olsen
Michael A. Castino
Transfer Agents
U.S. Bancorp Fund Services, LLC
Pricing Services
ICE Data Pricing & Reference Data, LLC
Custodians
U.S. Bank National Association
Shareholder Servicing Agents
N/A
Admins
U.S. Bancorp Fund Services, LLC
Brokers
VIRTU AMERICAS LLC
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
MISCHLER FINANCIAL GROUP, INC.
BOFAML SECURITIES, INC.
GOLDMAN SACHS & CO. LLC